Increased serum levels of TGFβ1 in children with localized scleroderma

BACKGROUND: There are neither sensitive nor specific laboratory tests for measuring disease activity in localized scleroderma (LS). Monitoring is done almost exclusively by clinical assessment. Our aim was to determine whether serum concentrations of TGFβ1 are a good biomarker of disease activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Uziel, Yosef, Feldman, Brian M, Krafchik, Bernice R, Laxer, Ronald M, Yeung, Rae SM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233624/
https://www.ncbi.nlm.nih.gov/pubmed/18053185
http://dx.doi.org/10.1186/1546-0096-5-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233624/
https://www.ncbi.nlm.nih.gov/pubmed/18053185
http://dx.doi.org/10.1186/1546-0096-5-22

Ejemplares similares